The US Food & Drug Administration is responding to a Congressional directive to improve its guidance development process with some ideas for enhancements – and a lot of data to suggest that it has already made significant strides.
The agency released a draft report outlining potential changes to its Good Guidance Practices, including the possibility of issuing more guidances for “immediate implementation.” (Also see "US FDA...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?